EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Therapeutic Effects of Lifei Decoction in a Murine Model of COPD Induced by LPS and Cigarette Smoke

Liguo Lu, Chengdong Zhu, Jian Xu, Yulan Hu, Juxiang Dai, Sheng Wang, Tao Wei

International Journal of Chronic Obstructive Pulmonary Disease · 2024

DOI: 10.2147/copd.s449521 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2024. Verfasst von Liguo Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, People's Repub…. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Disease Models, Animal, Lung, Drugs, Chinese Herbal. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The Lifei Decoction (LD) is a commonly utilized Chinese medicine for the treatment of sepsis and bronchial inflammation. However, its therapeutic potential in chronic obstructive pulmonary disease (COPD) remains unknown. Therefore, the objective of this study was to investigate the therapeutic efficacy and underlying mechanism of LD in a mouse model of COPD induced by cigarette smoke (CS) combined with lipopolysaccharide (LPS).

Methods

Hematoxylin-eosin (H&E) staining was employed to observe the pathological alterations in lung tissue, while ELISA was utilized for the detection of levels of inflammatory factors in both lung tissue and bronchoalveolar lavage fluid (BALF). Additionally, Western blot analysis was conducted to assess the expression of p-NF-κB, GDF11, ZO-1, and Occludin-1 proteins. The changes in intestinal flora were evaluated using the viable bacteria count method.

Results

The administration of LD demonstrates significant efficacy in mitigating pulmonary tissue damage in a murine model, while concurrently inhibiting the activation of the inflammatory pathway NF-κB to attenuate the levels of pro-inflammatory factors. Moreover, LD exhibits the capacity to enhance the expression of intestinal functional proteins ZO-1 and Occludin-1, thereby rectifying dysbiosis within the gut microbiota.

Conclusion

The LD shows great promise as a potential treatment for COPD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveDisease Models, AnimalLungDrugs, Chinese HerbalLipopolysaccharidesZonula Occludens-1 ProteinNF-kappa BOccludinInflammation MediatorsAnti-Inflammatory AgentsSignal TransductionAnimalsMaleGastrointestinal MicrobiomeMice, Inbred C57BLSmokeBronchoalveolar Lavage FluidCigarette SmokingMice

Stichwörter der Autor:innen

COPDinflammationintestinal floralifei decoction

Substanzen

Drugs, Chinese HerbalLipopolysaccharidesZonula Occludens-1 ProteinNF-kappa BOccludinInflammation MediatorsAnti-Inflammatory AgentsTjp1 protein, mouseSmokeOcln protein, mouse

Autor:innen und Institutionen

  • Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, People's Republic of China.
  • Department of Respiratory and Critical Care Medicine, Shuyang Hospital, The Affiliated Shuyang Hospital of Xuzhou Medical University, Suqian, People's Republic of China.
  • Department of Traditional Chinese Medicine, Shuyang Hospital, The Affiliated Shuyang Hospital of Xuzhou Medical University, Suqian, People's Republic of China.
  • Taian Maternal and Child Health Hospital, Tai An, Shandong, People's Republic of China.
  • Public Experimental Research Center, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.

Zitieren

APA

Lu, L., Zhu, C., Xu, J., Hu, Y., Dai, J., Wang, S., & Wei, T. (2024). Therapeutic Effects of Lifei Decoction in a Murine Model of COPD Induced by LPS and Cigarette Smoke. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s449521

Vancouver

Lu L, Zhu C, Xu J, Hu Y, Dai J, Wang S, et al. Therapeutic Effects of Lifei Decoction in a Murine Model of COPD Induced by LPS and Cigarette Smoke. International Journal of Chronic Obstructive Pulmonary Disease. 2024. doi:10.2147/copd.s449521

BibTeX
@article{Lu2024,
  author = {Lu, Liguo and Zhu, Chengdong and Xu, Jian and Hu, Yulan and Dai, Juxiang and Wang, Sheng and Wei, Tao},
  title = {Therapeutic Effects of Lifei Decoction in a Murine Model of COPD Induced by LPS and Cigarette Smoke},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2024},
  doi = {10.2147/copd.s449521}
}
Kostenlos starten →